Deal of the Day — limited-time pharmacy picks!
Actrapid HM Penfill 100 IU Injection 3 ml Cartridge

Actrapid HM Penfill 100 IU Injection 3 ml Cartridge

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Human insulin (100IU)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

5 Cartridge

About The Product

Controls blood sugar spikes after meals.

Description

Actrapid HM penfill 100 IU Injection 3MI is a prescription based medication that is used to treat Type 1 and Type 2 diabetes mellitus. This is a short acting human insulin that is used in diabetes management.

Its generic name is Human insulin which should be taken in 100ml of concentration. It contains insulin with the active ingredient, that helps lower blood glucose level by allowing the body's cells to absorb glucose for energy.

Doctors provide this medication for both adults and children based on individual needs and blood sugar control. Don't self administer the injection without consulting the doctor.

Indication

Controls blood sugar

Common side effects

  • Actrapid HM penfill show various side effects like other medication have, patient feel mild as well as severe side effects.
  • Consult the doctor about its symptoms : ● Hypoglycemia (low blood glucose level) ● Anxiety ● Headache ● Nervousness ● Shakiness ● Weight gain ● Pain and swelling ● Redness ● Fast heart rate ● High blood pressure

Dosage and duration

  • Doctors recommend injecting the injection before 15-20 minutes before the meal to control the post meal blood sugar.
  • It should be injected into the abdomen, thigh and upper arms of the patient.
  • Do not stop taking it unless the doctor tells you to do it.
  • Actrapid HM penfill 100 IU is the part of the treatment plan that should also include a healthy diet, regular exercise and weight reduction as advised by the doctor.

Mechanism of action

Insulin which is present in Actrapid HM penfill 100 IU Injection, helps to move glucose into the blood cells. These cells use glucose for energy which keeps the blood sugar level under control.

It works similar to the insulin produced, it facilitates reuptake of sugar in muscle and also suppresses the production of sugar in the liver.

Safety advice

Alcohol
Patients avoid alcohol while taking Actrapid HM penfill 100 IU injection because it interrupt with the treatment and may cause dangerous fluctuations in blood sugar levels increasing the risk of hypoglycemia and hyperglycemia.
Driving
Consult the doctor if Actrapid HM penfill should be taken or not while the patient is on the treatment.
Pregnancy
Actrapid HM penfill is not taken by pregnant women unless prescribed, as careful monitoring is required to manage blood sugar safely during pregnancy.
Breast Feeding
The women who breastfeed their child should avoid using Actrapid HM poenfill 100 IU injection as insulin may affect the child and its used should only be better under strict medical condition.
Kidney
Actrapid HM penfill is not used by kidney patient without medical supervision, as it can affect the function of kidney.
Liver
Consult a doctor before taking Actrapid HM penfill 100 IU injection if you are a patient of liver cancer, as liver function can affect how insulin is metabolized and increase the risk of side effects.

FAQs

Actrapid HM penfill 100 IU injection is taken by the patient with Type 1 and Type 2 diebetes mellitus to help control blood sugar levels.

Reference

• Erdnüß, F., Mohr, A., & Krämer, I. (2022).

Longterm physicochemical stability of ready-to-administer human insulin injection solutions 1 IU/mL in 50 mL plastic syringes. Pharmaceutical Technology in Hospital Pharmacy, 7(1), 20210014. • Katahira, M., Hara, I., & Nishizaki, T.

(2005). Insulin allergy decreased by Humulin S (Humulin R) and not by insulin aspart or Actrapid Penfill (Penfill R).

Diabetic medicine, 22(10), 1455-1457. • Schulze, J., & Rietzsch, H. (2014).

7.6 Insulin therapy. A Practical Guide to the Therapy of Type-II-Diabetes: Pathophysiology, Metabolic Syndrome, Differential Therapy, Late Complications, 160. • Schedule, D., & Agent, A.

(2009). Novo Nordisk Canada Inc. • Santhanam, R., Sharma, S.

K., Lomte, N., Baig, L., Kale, S., Chauthankar, S., ... & Jaiswal, A. (2025).

Assessing Biosimilarity of Insulin Aspart Injection and NovoRapid® Through Pharmacokinetic and Pharmacodynamic Comparisons in Healthy Volunteers: A Double-Blind, Randomized, Crossover Study. European Journal of Pharmacology, 177881.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026